Two widely used weight loss drugs could significantly reduce the risk of complications in people with the most common type of heart failure A new study reported that semaglutide and tirzepatide effectively lowered the risk of being hospitalized for The findings show that semaglutide, commonly sold under the brand names Ozempic, Wegovy, and Rybelsus, produced similar benefits to those produced by tirzepatide, commonly sold under the brand names Zepbound and Mounjaro
I would caution patients who already have a diagnosis of gastroparesis not to use this medication and make all patients aware of this
Many clinical trials have found that patients can lose significantly more weight with GLP-1s than they can with traditional diet and exercise plans alone
Oana Health, for example, offers a personalized approach that combines GLP-1 treatments with therapies like Metformin to tackle insulin resistance, weight management, and other PCOS symptoms
B12 is a water-soluble vitamin with no established upper toxicity limit